RIGL News and Press, Rigel Pharmaceuticals Inc. From 12/07/25

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition PR Newswire R289 continues to be generally well tolerated and at doses of ≥500 mg QD preliminary efficacy was observed i...

2025-12-04 16:38:09 ET More on markets 2026 Prediction: A Tapped-Out Consumer Could Bring The Recession And Market Correction A Weaker Dollar As The Fed Moves Toward Neutral: 3 Calls For FX Feels Normal, But Bounded By Extremes: 3 Calls For Rates Top 5 macro ...

2025-11-26 08:15:38 ET Rigel Pharma (NASDAQ: RIGL ) is a mature and profitable biotech, founded in 1996 and headquartered in South San Francisco. The company has three FDA approved medicines focusing in hematologic disorders and cancer. These drugs were approved in 2018, 2020 and 20...

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif. , Nov. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cance...

2025-11-25 18:01:00 ET Shares of hematologic and oncology concern Rigel Pharmaceuticals, Inc. ( RIGL ) have moved up sharply over the past month. The rally is being propelled by much better than expected Q3 results that posted earlier in this month. All three of its commerci...

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of...

Rigel to Present at the Jefferies Global Healthcare Conference in London PR Newswire SOUTH SAN FRANCISCO, Calif. , Nov. 12, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and canc...

2025-11-05 12:38:45 ET More on Rigel Pharmaceuticals Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout Rige...

2025-11-05 12:33:58 ET DENVER, Colo., Nov 05, 2025 ( 247marketnews.com )- Markets were in rhythm by midday as a string of biotech, entertainment, and tech names posted standout results or strategic updates that struck bullish chords across multiple sectors. Rigel Pharmaceuticals (...

2025-11-04 20:07:15 ET More on Rigel Pharmaceuticals Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout Rige...